4//SEC Filing
Larson Eric D 4
Accession 0000899243-20-019855
CIK 0001807901other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:28 PM ET
Size
7.6 KB
Accession
0000899243-20-019855
Insider Transaction Report
Form 4
Larson Eric D
Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2020-07-17+27,500→ 27,500 totalExercise: $18.00Exp: 2030-07-16→ Common Stock (27,500 underlying) - Purchase
Common Stock
2020-07-21$18.00/sh+600$10,800→ 22,125 total
Footnotes (2)
- [F1]Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
- [F2]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on March 25, 2021, with the remainder of the shares vesting in equal monthly installments following March 25, 2021 through March 25, 2024, subject to the reporting person's continued service on each applicable vesting date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
Related Parties
1- filerCIK 0001688239
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 7:28 PM ET
- Size
- 7.6 KB